{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:25:41Z","timestamp":1749939941583},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbr.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T23:51:58Z","timestamp":1477353118000},"page":"508-514","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack"],"prefix":"10.1016","volume":"317","author":[{"given":"Luara A.","family":"Batista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea S.","family":"Haibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz C.","family":"Schenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2016.10.017_bib0005","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC . 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.bbr.2016.10.017_bib0010","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1192\/bjp.163.2.201","article-title":"Subtyping of panic disorder by symptom profile","volume":"163","author":"Briggs","year":"1993","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2016.10.017_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/070674370204700719","article-title":"Carbon dioxide test in respiratory panic disorder subtype","volume":"47","author":"Nardi","year":"2002","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2016.10.017_bib0020","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1176\/ajp.146.2.148","article-title":"A neuroanatomical hypothesis for panic disorder","volume":"146","author":"Gorman","year":"1989","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2016.10.017_bib0025","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.neubiorev.2008.05.017","article-title":"Neurobiology of panic disorder: from animal models to brain neuroimaging","volume":"32","author":"Graeff","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7\u20138","key":"10.1016\/j.bbr.2016.10.017_bib0030","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","article-title":"Modeling panic attacks","volume":"25","author":"Schenberg","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"26","key":"10.1016\/j.bbr.2016.10.017_bib0035","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1523\/JNEUROSCI.0408-06.2006","article-title":"Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors","volume":"26","author":"Johnson","year":"2006","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.bbr.2016.10.017_bib0040","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1523\/JNEUROSCI.17-24-09726.1997","article-title":"The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder","volume":"17","author":"Shekhar","year":"1997","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bbr.2016.10.017_bib0045","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0006-3223(02)01733-X","article-title":"Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala","volume":"53","author":"Sullivan","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0050","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2016.10.017_bib0055","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1037\/0022-006X.65.2.203","article-title":"Misinterpretation of body sensations in panic disorder","volume":"65","author":"Clark","year":"1997","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0060","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/archpsyc.1993.01820160076009","article-title":"False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis","volume":"50","author":"Klein","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2016.10.017_bib0065","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/anxi.3070010103","article-title":"Testing the suffocation false alarm theory of panic disorder","volume":"1","author":"Klein","year":"1994","journal-title":"Anxiety"},{"issue":"3","key":"10.1016\/j.bbr.2016.10.017_bib0070","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nn.3323","article-title":"Fear and panic in humans with bilateral amygdala damage","volume":"16","author":"Feinstein","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2016.10.017_bib0075","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/archneur.63.12.1798","article-title":"Panic attacks in an individual with bilateral selective lesions of the amygdala","volume":"63","author":"Wiest","year":"2006","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.bbr.2016.10.017_bib0080","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1523\/JNEUROSCI.4109-15.2016","article-title":"Panic anxiety in humans with bilateral amygdala lesions: pharmacological induction via cardiorespiratory interoceptive pathways","volume":"36","author":"Khalsa","year":"2016","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2016.10.017_bib0085","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.neubiorev.2014.10.002","article-title":"Translational approach to studying panic disorder in rats: hits and misses","volume":"46","author":"Schenberg","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2016.10.017_bib0090","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuroscience.2011.10.032","article-title":"Evidence of a suffocation alarm system within the periaqueductal gray matter of the rat","volume":"200","author":"Schimitel","year":"2012","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.bbr.2016.10.017_bib0095","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1177\/0269881114552714","article-title":"Evidence of a suffocation alarm system sensitive to clinically-effective treatments with the panicolytics clonazepam and fluoxetine","volume":"28","author":"Schimitel","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2016.10.017_bib0100","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-1838(93)90342-R","article-title":"Cardiovascular responses of conscious rats to carotid body chemoreceptor stimulation by intravenous KCN","volume":"42","author":"Franchini","year":"1993","journal-title":"J. Auton. Nerv. Syst."},{"issue":"2","key":"10.1016\/j.bbr.2016.10.017_bib0105","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/npp.2011.207","article-title":"Opposing roles for cannabinoid receptor type-1 (CB(1)) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats","volume":"37","author":"Casarotto","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2016.10.017_bib0110","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pbb.2013.02.012","article-title":"Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats","volume":"105","author":"Almeida-Santos","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.bbr.2016.10.017_bib0115","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00213-014-3793-x","article-title":"Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats","volume":"232","author":"Viana","year":"2015","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2016.10.017_bib0120","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/0269881114566259","article-title":"Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses","volume":"29","author":"Batista","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2016.10.017_bib0125","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pbb.2013.05.013","article-title":"Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze","volume":"110","author":"Gobira","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0130","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.bbr.2016.10.017_bib0135","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0028-3908(03)00235-1","article-title":"Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats","volume":"45","author":"Finn","year":"2003","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2016.10.017_bib0140","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00213-003-1629-1","article-title":"Cannabinoids modulate ultrasound-induced aversive responses in rats","volume":"172","author":"Finn","year":"2004","journal-title":"Psychopharmacology"},{"issue":"5\u20136","key":"10.1016\/j.bbr.2016.10.017_bib0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/FBP.0000000000000073","article-title":"Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs","volume":"25","author":"Batista","year":"2014","journal-title":"Behav. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbr.2016.10.017_bib0150","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0155","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1607","key":"10.1016\/j.bbr.2016.10.017_bib0160","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B: Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2016.10.017_bib0165","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2016.10.017_bib0170","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology"},{"issue":"4 Pt 2","key":"10.1016\/j.bbr.2016.10.017_bib0175","article-title":"NMDA receptors in NTS are involved in bradycardic but not in pressor response of chemoreflex","volume":"269","author":"Haibara","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"1 Pt 2","key":"10.1016\/j.bbr.2016.10.017_bib0180","first-page":"R69","article-title":"Sympathoexcitatory neurotransmission of the chemoreflex in the NTS of awake rats","volume":"276","author":"Haibara","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbr.2016.10.017_bib0185","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2015.08.045","article-title":"Serotonin in the dorsal periaqueductal gray inhibits panic-like defensive behaviors in rats exposed to acute hypoxia","volume":"307","author":"Spiacci","year":"2015","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.bbr.2016.10.017_bib0190","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/npp.2012.38","article-title":"Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia","volume":"37","author":"Johnson","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2016.10.017_bib0195","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1113\/expphysiol.2010.054080","article-title":"Excitatory amino acid receptors in the dorsomedial hypothalamus are involved in the cardiovascular and behavioural chemoreflex responses","volume":"96","author":"Queiroz","year":"2011","journal-title":"Exp. Physiol."},{"issue":"2","key":"10.1016\/j.bbr.2016.10.017_bib0200","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuroscience.2008.08.070","article-title":"Intermittent activation of peripheral chemoreceptors in awake rats induces Fos expression in rostral ventrolateral medulla-projecting neurons in the paraventricular nucleus of the hypothalamus","volume":"157","author":"Cruz","year":"2008","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bbr.2016.10.017_bib0205","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1590\/S0001-37652005000300009","article-title":"Does the panic attack activate the hypothalamic-pituitary-adrenal axis?","volume":"77","author":"Graeff","year":"2005","journal-title":"An. Acad. Bras. Cienc."},{"issue":"7045","key":"10.1016\/j.bbr.2016.10.017_bib0210","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbr.2016.10.017_bib0215","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/j.1476-5381.2011.01478.x","article-title":"The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone","volume":"165","author":"Olango","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.bbr.2016.10.017_bib0220","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.21.12198","article-title":"Pain modulation by release of the endogenous cannabinoid anandamide","volume":"96","author":"Walker","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2b","key":"10.1016\/j.bbr.2016.10.017_bib0225","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1476-5381.2011.01388.x","article-title":"The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys","volume":"164","author":"Stewart","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2016.10.017_bib0230","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.euroneuro.2015.02.005","article-title":"The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs\u2014a practical view","volume":"25","author":"Fowler","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Pt 3","key":"10.1016\/j.bbr.2016.10.017_bib0235","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.neubiorev.2014.03.026","article-title":"Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels","volume":"46","author":"Aguiar","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.bbr.2016.10.017_bib0240","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0245","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1517\/13543784.2014.996286","article-title":"Novel investigational therapeutics for panic disorder","volume":"24","author":"Perna","year":"2015","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"2\u20133","key":"10.1016\/j.bbr.2016.10.017_bib0250","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1016\/S0014-2999(97)00146-5","article-title":"Delta 9-tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain","volume":"323","author":"Burkey","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"32","key":"10.1016\/j.bbr.2016.10.017_bib0255","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.bbr.2016.10.017_bib0260","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2016.10.017_bib0265","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.bbr.2016.10.017_bib0270","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/cmdc.200900210","article-title":"A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo","volume":"4","author":"Clapper","year":"2009","journal-title":"ChemMedChem"},{"issue":"8","key":"10.1016\/j.bbr.2016.10.017_bib0275","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.euroneuro.2009.02.001","article-title":"adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain","volume":"19","author":"Barna","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0280","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.bbr.2016.10.017_bib0285","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3109\/10673229.2010.493744","article-title":"Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment","volume":"18","author":"Freire","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.bbr.2016.10.017_bib0290","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-1-4615-1375-9_70","article-title":"Central and peripheral chemoreflex characteristics: panic disorder patients vs. healthy volunteers","volume":"499","author":"Struzik","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.bbr.2016.10.017_bib0295","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1569-9048(02)00170-2","article-title":"Effects of tryptophan depletion on central and peripheral chemoreflexes in man","volume":"133","author":"Struzik","year":"2002","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbr.2016.10.017_bib0300","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0893-133X(02)00283-X","article-title":"The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers","volume":"26","author":"Katzman","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.10.017_bib0305","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0165-1781(02)00238-X","article-title":"Central and peripheral chemoreflexes in panic disorder","volume":"113","author":"Katzman","year":"2002","journal-title":"Psychiatry Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816307999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816307999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:18:52Z","timestamp":1601158732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816307999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":61,"alternative-id":["S0166432816307999"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.10.017","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}